GL1X · GenesisL1 explorer

MolNFT v1 · #135690 · protein

Discovery of mli-2, an orally available and selective LRRK2 inhibitor that reduces brain kinase activity

5U6I · Mitogen-activated protein kinase 1: “Discovery of mli-2, an orally available and selective LRRK2 inhibitor that reduces brain kinase activity”. X-ray diffraction, 2 ligands (81Y, SO4), 4 pockets (best druggability 0.61). MolNFT v1…

PDB
5U6I
Type
protein
Length
339 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P63086
Ligands
81Y, SO4
Pockets
4 · best druggability 0.61

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33941% helix, 14% strandP63086

Ligands and binding sites

  • 81Y · 3-[2-(morpholin-4-yl)pyridin-4-yl]-5-[(propan-2-yl) oxy]-1H-indazole · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11840.610.832781Y
21150.490.8019empty
31220.490.7926empty
4780.370.7718SO4

Compared structures

  • 5U6I · Discovery of MLi-2, an Orally Available and Selective LRRK2 Inhibitor that Reduces Brain… · the same entry in another collection · chain A against A, TM-score 1.00
  • P63086 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 1 (P63086) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.